Indoco Remedies Limited — PPTs, 24-10-2024: Investor Presentation

Indoco Remedies Limited shared its investor presentation detailing unaudited financial results for Q2 and H1 FY25. Key highlights include a revenue decline to INR 3,946 million with a PAT of INR 128 million, reflecting a 3.2% margin. The company continues to expand its footprint across international markets and boasts a strong product pipeline, including successful launches and approvals. Indoco's manufacturing facilities are compliant with global standards, supporting robust growth.